Kolexia
Phelip Jean-Marc
Gastro-entérologie
Hôpital Nord CHU Saint-Étienne - Loire
Saint-Priest-en-Jarez, France
374 Activités
888 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Métastase tumorale Tumeurs du pancréas Tumeurs du rectum Tumeurs du foie Tumeurs du côlon Maladies inflammatoires intestinales Carcinomes

Industries

Merck
41 collaboration(s)
Dernière en 2023
Sanofi
39 collaboration(s)
Dernière en 2022
Servier
36 collaboration(s)
Dernière en 2023
Merck-Serono
36 collaboration(s)
Dernière en 2023

Dernières activités

MOUNTAINEER-03: An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer
Essai Clinique (Seagen)   15 mars 2024
ASO Visual Abstract: Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.
Annals of surgical oncology   06 mars 2024
SERPAN: SERum-bank for PANcreatic Cancer
Essai Clinique (CHU Saint-Étienne)   16 février 2024
Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.
Annals of surgical oncology   03 janvier 2024
161P Screening and COnsensus based on Practices and Evidence (SCOPE): Real-world survey on Japanese and rest-of-world practice patterns in resectable pancreatic cancer
Abstract Book of the ESMO Asia Congress 2023, 1-3 December 2023   01 novembre 2023
Top 2 des articles publiés en 2022 sur les tumeurs œsogastriques
Edimark   20 octobre 2023
Formation médicale en continu et recherche clinique : les indissociables !
Edimark   20 octobre 2023
Inhibition d’HER2 en oncologie digestive : pour quelles tumeurs et pour quels patients ?
Edimark   20 octobre 2023
MRI in rectal cancer: An institutional real life analysis of technical parameters.
Bulletin du cancer   17 octobre 2023
608P Resectability of colorectal liver metastases (CLM) with aflibercept plus FOLFIRI: Results from a prospective French cohort
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023